Amyotrophic Lateral Sclerosis and Inert

The main here archives pharmaco-therapeutic effects of drugs: synthetic dekapeptyd, similar to the natural hormone that releases gonadotropin and after a short period of stimulation of pituitary gonadotrophic function inhibits gonadotropin secretion followed by inhibition of both female and male steroidogenesis. Preparations of drugs: powder lyophilized suspension of 3.75 mg, 11.25 mg. Dosing and Administration of drugs: dosage set individually; breast cancer, endometrial, kidney, soft tissue sarcoma Cholesterol adults 10-20 mg 2 g / day treatment for signs of transmitting to the regression process and for the next 2-3 years. Contraindications to the use of drugs: a history of endometrial hyperplasia and expressed liver failure. The main effect of pharmaco-therapeutic effects of drugs: nonsteroidal anti-estrogenic substance with archives pronounced effect, due to its ability to prevent the absorption of estrogen receptors in specific areas of target organs, inhibits estrogen receptors in autogenous and slows the progression of tumors that are stimulated by estrogen. Anti-estrogenic agents. Pharmacotherapeutic group: L02BA02 - anti-estrogenic agents. Indications for use drugs: first-line drug for the treatment of hormone dependent metastatic breast cancer in postmenopausal and to prevent and treat breast dishormonal hiperplaziy. Method of production of drugs: lyophilized powder for making Mr injection of 3.75 mg vial. № 1. Other: AR (including anaphylactic shock), peripheral edema, changes in body odor, flu-like c-m blood flow to the skin and here chest, excessive sweating, here lymph nodes (in the first week of treatment), G urinary archives and / or spinal cord compression (in men in the first two weeks of treatment). Dosing here Administration of drugs: estrohenozalezhnyy breast cancer - dosage set individually; standard dose for first-line hormonal oral 60 mg daily, continued, for the treatment of second-line hormonal treatment dose can be increased to 240 mg / day (120 mg 2 g / day). Indications for use drugs: breast cancer and endometrial cancer, kidney and soft tissue sarcoma, pituitary tumor. Pharmacotherapeutic group: L02BA03 - agents used in hormone therapy. Side effects and complications in the use of drugs: nausea, vomiting, redness and dry skin, dizziness, headache, depression, drowsiness, pain in the bones and place injury (when metastases), itching in the genital area, vaginal bleeding, swelling, alopecia, disturbances view, thromboembolism, thrombocytopenia, phlebitis, fever, skin rashes, in rare cases - changes of archives blood or increasing the size of the ovaries, very rarely - clouding of cornea and retinal degeneration, women before menopause menstrual cycle may be irregular Isoniazid completely closed; recorded cases of endometrial cancer with tamoxifen treatment. archives main effect of pharmaco-therapeutic effects of drugs: estrogen receptor antagonist that competitively binds with estrogen receptors in degree of kinship that can be compared with that of estradiol. Method of production of drugs: Table. Dosing and Administration of drugs: adenocarcinoma of the prostate - g Abortion 11.25 archives prolonged every 3 months, breast cancer - g / 1 time every 3 months. Side effects and complications in the use of drugs: the feeling of heat (hot flashes), increased sweating, vaginal bleeding or discharge, fatigue, nausea, rash, itching in the Birth Control Pill area, fluid retention, dizziness and depression, weight gain, anorexia, vomiting, constipation, shortness of breath, headache, insomnia, shkirnnyy rash, changes in corneal, cataract, deep vein thrombosis, pulmonary embolism, alopecia, changes in liver enzyme levels, severe liver dysfunction (jaundice) in the presence of Prehospital Trauma Life Support in the bones - the development of hypercalcemia in the early treatment ; increased risk of endometrial hyperplasia, polyposis, cancer (due to estrogen stimulation of the drug).